PDPN levels are increased in stromal cells of the tumor microenvironment, including lymphatic endothelial cells, immune cells [85], and cancer-associated fibroblasts (CAFs); these non-malignant cells have diverse roles in cancer progression (Table 2). The gene discussed is PDPN; the disease is cancer.